Patents by Inventor Johannes Schmitt

Johannes Schmitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210223748
    Abstract: A method for providing an evaluation and control model for controlling target building automation devices of a target building automation system includes: providing a plurality of pre-trained source evaluation and control models for controlling source building automation devices of a source building automation system; generating for each pre-trained source evaluation and control model a semantic based description of a context in which the model was trained; generating a semantic based description of the context of the target building automation system; retrieving the semantic based description of the context of each pre-trained source evaluation and control model of the plurality of pre-trained source evaluation and control models; and matching the generated semantic based description of the context of the target building automation system and the semantic based description of the context in which the pre-trained source evaluation and control models were trained by using a semantic matchmaking concept.
    Type: Application
    Filed: December 22, 2020
    Publication date: July 22, 2021
    Inventors: Johannes Schmitt, Christian Gross
  • Publication number: 20210184391
    Abstract: A cable connector housing for hazardous areas includes: a first part; a second part; a first cable gland; and a second cable gland. The first part connects to and separates from the second part. When the first part is connected to the second part a cavity is formed within which a cable connector is housable. The first cable gland connects to the first part. The first cable gland connects to a part of a first cable that is for use in a hazardous area. The second cable gland connects to the second part. The second cable gland connects to part of a second cable that is for use in the hazardous area. The first part, second part, first cable gland, and second cable gland are arranged such that when the first part is connected to the second part, a connector housing is formed that for use in the hazardous area.
    Type: Application
    Filed: November 25, 2020
    Publication date: June 17, 2021
    Inventors: Johannes SCHMITT, Benjamin BUENGEL, Matthias GUTH
  • Patent number: 11038706
    Abstract: A computer-implemented method for semantic-based planning, engineering, and commissioning a project in a building or home automation system, using multiple technologies/protocols of devices including sensors, actuators and control devices, the method being based on a semantic based model having an automatic configuration generation for specific technologies/protocols from a function-based device specification, the method including the following multiple transformation steps: calculating/creating a configuration for a specific protocol/technology using a mapping complex or structure of rules or processing instructions that takes into account the semantic-based model, technology models, heuristics, and/or technology constraints of the devices; generating an internal model of the building automation system with communication objects as an output of the automatic created configuration calculation; transforming the internal model, depending on a targeted technology/protocol, in order to create either application p
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: June 15, 2021
    Assignee: ABB SCHWEIZ AG
    Inventors: Somayeh Malakuti, Johannes Schmitt, Thomas Gamer
  • Publication number: 20210128587
    Abstract: A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin Dora metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject.
    Type: Application
    Filed: December 11, 2017
    Publication date: May 6, 2021
    Inventors: Gene Bowman, Julie Laure Hudry-Labbe, Jeroen Antonius Johannes Schmitt, Corina Boschat
  • Publication number: 20210109506
    Abstract: A production line for manufacturing a building block, which includes at least one component, the production line including: a central conveyor line; at least one feeding line for feeding the at least one component to the central conveyor line; a manufacturing tool set for processing the at least one component; and a control unit for controlling the central conveyor line, the feeding line, and/or the manufacturing tool set. The controlling at least one of the central conveyor line, the feeding line, and/or the manufacturing tool set includes: retrieving an asset-information about the at least one component and/or the manufacturing tool set, conveying the at least one component according to the asset-information by the feeding line to the central conveyor line, retrieving a processing-information and/or a manufacturing tool set information about processing the at least one component, and processing the at least one component by the manufacturing tool set.
    Type: Application
    Filed: October 14, 2020
    Publication date: April 15, 2021
    Inventors: Somayeh Malakuti, Prerna Juhlin, Sten Gruener, Johannes Schmitt
  • Publication number: 20210060096
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to stabilize or improve mood, modulate excessive emotional distress, reduce anxiety, and/or reduce stress. In an embodiment, the composition can be administered daily for at least three weeks.
    Type: Application
    Filed: November 17, 2020
    Publication date: March 4, 2021
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Patent number: 10912803
    Abstract: A composition containing the probiotic strain Lactobacillus johnsonii CNCM 1-1225 in combination with a polyphenol for use in the treatment or prevention of a cognitive and/or neurodegenerative disorder, in particular Alzheimer's disease. The polyphenol can be one or more of rosmarinic acid, chicoric acid, or caftaric acid, and can be provided in the form of a plant extract.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: February 9, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Rachid Bel-Rhlid, Jane Durga, Tina Kunz, Jeroen Antonius Johannes Schmitt
  • Publication number: 20210011968
    Abstract: An industrial information identification and retrieval system includes: a crawler; a search engine; a result processor; and a web user interface “web UL” The crawler identifies devices and their associated Open Platform Communication Unified Architecture “OPC UA” servers within a network as identified OPC UA servers. The crawler browses the identified OPC UA servers and extracts and stores data items in a database as extracted data items. The search engine searches the extracted data items and provides search results to the result processor. The result processor determines a score for each search result. The web UI presents the search results according to the scores.
    Type: Application
    Filed: July 8, 2020
    Publication date: January 14, 2021
    Inventors: Andreas Burger, Heiko Koziolek, Sten Gruener, Johannes Schmitt, Marcel Dix
  • Publication number: 20210010933
    Abstract: A process analyzer adapter includes: a first part connectable to a process analyzer, the first part being rotatable about a first axis; a second part; and a third part. The first part is rotationally connected to the second part. The second part is rotationally connected to the third part. The second part is rotatable about a second axis, rotation of the second part about the second axis tilting the first axis. The third part is connectable to a flange of an industrial process equipment.
    Type: Application
    Filed: July 3, 2020
    Publication date: January 14, 2021
    Inventors: Johannes Schmitt, Peter Weil, Jens Kubatta, Daniel Voss, Benjamin Buengel
  • Publication number: 20210008130
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; “empty” feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 14, 2021
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Patent number: 10821139
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; “empty” feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: November 3, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Patent number: 10821130
    Abstract: A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid, a nitric oxide releasing compound, and Vitamin B12. The composition is administered in a daily dose that provides 50 to 500 times the recommended daily requirement (RDA) of Vitamin B12 per day, for example about 200 times the RDA of Vitamin B12 per day. Optionally Vitamin B6 and/or Vitamin B9 can be included in the composition. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-? phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: November 3, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Yvonne Beata Silber, Jeroen Antonius Johannes Schmitt, Corina Boschat, Julie Hudry-Labbe, Claus Rieker
  • Publication number: 20200054665
    Abstract: A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid, a nitric oxide releasing compound, Vitamin B12 and choline. The composition is administered in a daily dose that provides 0.1 to 50 times the recommended daily requirement (RDA) of Vitamin B12 per day, more preferably 0.1 to 40 times the recommended daily requirement (RDA) of Vitamin B12 per day and 0.01 to 10.0 times the recommended daily requirement (RDA) of choline. Optionally Vitamin B6 and/or Vitamin B9 can be included in the composition. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-? phagocytosis, or decreasing or maintaining neuro inflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human.
    Type: Application
    Filed: April 5, 2018
    Publication date: February 20, 2020
    Inventors: Claus Rieker, Julie Laure Hudry-Labbe, Jeroen Antonius Johannes Schmitt, Corina Boschat
  • Patent number: 10567533
    Abstract: The invention relates to a presence status determination system and a computer implemented method to determine the presence status of a first user registered in a network and to communicate this presence status to a second user, who would like to make contact with the first user. An input device for a presence status determination device records a predetermined first presence status component determined by the first user and forwards the first presence status component to the presence status determination device (20). A contact person registration device records the identity of the second user and reports the identity to a relationship determination device. The relationship determination device determines, with the aid of a computer, a second presence status component, which considers the social proximity between the first user and the second user.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: February 18, 2020
    Assignee: Unify GmbH & Co. KG
    Inventors: Andreas Reinhardt, Johannes Schmitt, Jurgen Totzke
  • Publication number: 20200046660
    Abstract: A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid and choline. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-? phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human. The composition can be administered to the individual in a daily dose that provides 5.5 mg/day to 5,500 mg/day of the choline, for example 85 mg/day to 3,500 mg/day of the choline.
    Type: Application
    Filed: September 29, 2017
    Publication date: February 13, 2020
    Inventors: Claus Rieker, Julie Hudry-Labbe, Jeroen Antonius Johannes Schmitt, Corina Boschat, Yvonne Beata Silber
  • Publication number: 20190280889
    Abstract: A computer-implemented method for semantic-based planning, engineering, and commissioning a project in a building or home automation system, using multiple technologies/protocols of devices including sensors, actuators and control devices, the method being based on a semantic based model having an automatic configuration generation for specific technologies/protocols from a function-based device specification, the method including the following multiple transformation steps: calculating/creating a configuration for a specific protocol/technology using a mapping complex or structure of rules or processing instructions that takes into account the semantic-based model, technology models, heuristics, and/or technology constraints of the devices; generating an internal model of the building automation system with communication objects as an output of the automatic created configuration calculation; transforming the internal model, depending on a targeted technology/protocol, in order to create either application p
    Type: Application
    Filed: March 6, 2019
    Publication date: September 12, 2019
    Inventors: Somayeh Malakuti, Johannes Schmitt, Thomas Gamer
  • Publication number: 20190209601
    Abstract: A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid, a nitric oxide releasing compound, and Vitamin B12. The composition is administered in a daily dose that provides 50 to 500 times the recommended daily requirement (RDA) of Vitamin B12 per day, for example about 200 times the RDA of Vitamin B12 per day. Optionally Vitamin B6 and/or Vitamin B9 can be included in the composition. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-? phagocytosis, or decreasing or maintaining neuroinflammation in N the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human.
    Type: Application
    Filed: September 29, 2017
    Publication date: July 11, 2019
    Inventors: Yvonne Beata Silber, Jeroen Antonius Johannes Schmitt, Corina Boschat, Julie Hudry-Labbe, Claus Rieker
  • Publication number: 20180250348
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; “empty” feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof.
    Type: Application
    Filed: August 31, 2016
    Publication date: September 6, 2018
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Publication number: 20180250349
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to stabilize or improve mood, modulate excessive emotional distress, reduce anxiety, and/or reduce stress. In an embodiment, the composition can be administered daily for at least three weeks.
    Type: Application
    Filed: August 31, 2016
    Publication date: September 6, 2018
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Publication number: 20180213047
    Abstract: The invention relates to a presence status determination system and a computer implemented method to determine the presence status of a first user registered in a network and to communicate this presence status to a second user, who would like to make contact with the first user. An input device for a presence status determination device records a predetermined first presence status component determined by the first user and forwards the first presence status component to the presence status determination device (20). A contact person registration device records the identity of the second user and reports the identity to a relationship determination device. The relationship determination device determines, with the aid of a computer, a second presence status component, which considers the social proximity between the first user and the second user.
    Type: Application
    Filed: March 16, 2018
    Publication date: July 26, 2018
    Inventors: Andreas Reinhardt, Johannes Schmitt, Jurgen Totzke